Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 04, 2021
Evonik has acquired German biotech company JeNaCell. The acquisition expands Evonik’s biomaterials portfolio to provide biotechnologically derived cellulose. The nature-identical material developed by JeNaCell is used in medical technology and ...
read more
Monday, November 17, 2025
Evonik has entered a strategic partnership with InVitria to supply animal component-free (ACF) recombinant human serum albumin to the global biopharmaceutical industry.
read more
Evonik entered into a long-term supply agreement with Phathom Pharmaceuticals. Through the agreement Evonik will produce large-scale volumes of vonoprazan at its FDA-inspected manufacturing sites in Tippecanoe, Indiana, USA and Dossenheim, Germany.
read more
Evonik is working with Stanford University on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles (LNPs). This polymer-based platform complements Evonik’s existing portfolio of lipid-based drug ...
read more
Thursday, August 04, 2022
Evonik is building a new cGMP facility to manufacture lipids for clinical development and launch of innovative medicines. The new cGMP lipid launch facility is located in Hanau, Germany and will provide customers with smaller batch sizes of lipids as...
read more
Evonik has closed its previously announced acquisition of the LACTEL Absorbable Polymers product line from DURECT on December 31, 2020.
read more
Wednesday, August 14, 2024
Evonik is collaborating with KNAUER Wissenschaftliche Geräte GmbH, a manufacturer of scientific instruments, to improve the upscaling of lipid nanoparticle (LNP) formulations. By combining Evonik’s formulation and scale-up expertise with KNAUER’s ...
read more
Wednesday, February 17, 2021
Evonik has announced an investment in short-term expansion of its specialty lipids production which are needed for mRNA-based COVID-19 vaccines.
read more
Evonik is building a new, highly flexible, global-scale production facility for pharmaceutical lipids in the United States. The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel ...
read more
Thursday, September 28, 2023
Evonik is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology.
read more
Evonik has entered into a supply agreement with Cassava Sciences, a clinical-stage biotechnology company focused on neuroscience.
read more
Monday, September 10, 2018
Evoqua Water Technologies has completed an exclusive sales and distribution agreement with Horizon Solutions to expand local service in Puerto Rico.
read more
Evotec AG and Aptuit have entered into a definitive agreement under which Evotec will acquire Aptuit for $ 300 million.
read more
Evotec AG
(Frankfurt:EVT) (TecDAX) today announced that it has extended and expanded its medicinal chemistry collaboration with Active Biotech AB (NASDAQ OMX: ACTI), to further advance an existing programme, which has entered the lead optimisation ...
read more
Evotec AG has announced that in line with its strategy to participate in promising corporate formations it will deepen its already existing relationship with Carrick. Evotec will invest up to $ 6 m towards Carrick's latest funding round.
read more